Page 109 - Read Online

59. Hodkinson PS, Elliott T, Wong WS, Rintoul RC, Mackinnon AC, Haslett Weller M, Goodman SL, Birner P, Preusser M. αvβ3, αvβ5 and αvβ6
C, Sethi T. ECM overrides DNA damage-induced cell cycle arrest integrins in brain metastases of lung cancer. Clin Exp Metastasis
and apoptosis in small-cell lung cancer cells through beta1 integrin- 2014;31:841-51.
dependent activation of PI3-kinase. Cell Death Differ 2006;13:1776-88. 77. Deryugina EI, Quigley JP. Tumor angiogenesis: MMP-mediated
60. Ali A1, Goffin JR, Arnold A, Ellis PM. Survival of patients with non- induction of intravasation- and metastasis-sustaining neovasculature.
small-cell lung cancer after a diagnosis of brain metastases. Curr Matrix Biol 2015;44-46:94-112.
Oncol 2013;20:300-6. 78. Rojiani MV, Alidina J, Esposito N, Rojiani AM. Expression of MMP-
61. Goldstraw P, Ball D, Jett JR, Le Chevalier T, Lim E, Nicholson AG, 2 correlates with increased angiogenesis in CNS metastasis of lung
Shepherd FA. Non-small-cell lung cancer. Lancet 2011;378:1727-40. carcinoma. Int J Clin Exp Pathol 2010;3:775-81.
62. Ceresoli GL, Cappuzzo F, Gregorc V, Bartolini S, Crinò L, Villa E. 79. Preusser M, Berghoff AS, Berger W, Ilhan-Mutlu A, Dinhof C,
Gefitinib in patients with brain metastases from non-small-cell lung Widhalm G, Dieckmann K, Wöhrer A, Hackl M, von Deimling A,
cancer: a prospective trial. Ann Oncol 2004;15:1042-7. Streubel B, Birner P. High rate of FGFR1 amplifications in brain
63. Lai CS, Boshoff C, Falzon M, Lee SM. Complete response to metastases of squamous and non-squamous lung cancer. Lung
erlotinib treatment in brain metastases from recurrent NSCLC. Cancer 2014;8:83-9.
Thorax 2006;61:91. 80. Lee HW, Seol HJ, Choi YL, Ju HJ, Joo KM, Ko YH, Lee JI, Nam DH.
64. Prudkin L, Liu DD, Ozburn NC, Sun M, Behrens C, Tang X, Moran C, Genomic copy number alterations associated with the early brain
Wistuba II. Epithelial-to-mesenchymal transition in the development metastasis of non-small cell lung cancer. Int J Oncol 2012;4:2013-20.
and progression of adenocarcinoma and squamous cell carcinoma of 81. Prat A, Perou CM. Deconstructing the molecular portraits of breast
the lung. Mod Pathol 2009;22:668-78. cancer. Mol Oncol 2011, 5;5-23.
65. Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, 82. Niikura N, Saji S, Tokuda Y, Iwata H. Brain metastases in breast
Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce cancer. Jpn J Clin Oncol 2014;44:1133-40.
CM, Harris CC. MiR-21 is an EGFR-regulated anti-apoptotic 83. Hung MH, Liu CY, Shiau CY, Hsu CY, Tsai YF, Wang YL, Tai
factor in lung cancer in never-smokers. Proc Natl Acad Sci USA LC, King KL, Chao TC, Chiu JH, Su CH, Lo SS, Tzeng CH, Shyr
2009;106:12085-90. YM, Tseng LM. Effect of age and biological subtype on the risk
66. Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, Muller RU, and timing of brain metastasis in breast cancer patients. PLoS One
Straka E, Su L, Burki EA, Crowell RE, Patel R, Kulkarni T, Homer R, 2014;9:e89389.
Zelterman D, Kidd KK, Zhu Y, Christiani DC, Belinsky SA, Slack FJ, 84. Venkitaraman R, Joseph T, Dhadda A, Chaturvedi A, Upadhyay S.
Weidhaas JB. A SNP in a let-7 microRNA complementary site in the Prognosis of patients with triple-negative breast cancer and brain
KRAS 3’ untranslated region increases non-small cell lung cancer risk. metastasis. Clin Oncol 2009;21:729-30.
Cancer Res 2008;68:8535-40. 85. Niikura N, Liu J, Hayashi N, Mittendorf EA, Gong Y, Palla SL,
67. Zhao C1, Xu Y, Zhang Y, Tan W, Xue J, Yang Z, Zhang Y, Lu Y, Hu X. Tokuda Y, Gonzalez-Angulo AM, Hortobagyi GN, Ueno NT. Loss
Downregulation of miR-145 contributes to lung adenocarcinoma cell of human epidermal growth factor receptor 2 (HER2) expression in
growth to form brain metastases. Oncol Rep 2013 Nov;30:2027-34. metastatic sites of HER2-overexpressing primary breast tumors. J
68. Zhang Y, Lin Q. MicroRNA-145 inhibits migration and invasion Clin Oncol 2012;30:593-9.
by down-regulating FSCN1 in lung cancer. Int J Clin Exp Med 86. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX,
2015;8:8794-802. Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA, Massagué
69. Donzelli S, Mori F, Bellissimo T, Sacconi A, Casini B, Frixa T, J. Genes that mediate breast cancer metastasis to the brain. Nature
Roscilli G, Aurisicchio L, Facciolo F, Pompili A, Carosi MA, 2009;459:1005-9.
Pescarmona E, Segatto O, Pond G, Muti P, Telera S, Strano S, Yarden 87. Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C,
Y, Blandino G. Epigenetic silencing of miR-145-5p contributes to Gomis RR, Manova-Todorova K, Massagué J. Mediators of vascular
brain metastasis. Oncotarget 2015;6:35183-201. remodelling co-opted for sequential steps in lung metastasis. Nature
70. Arora S, Ranade AR, Tran NL, Nasser S, Sridhar S, Korn RL, Ross 2007;446:765-70.
JT, Dhruv H, Foss KM, Sibenaller Z, Ryken T, Gotway MB, Kim 88. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, van’t
S, Weiss GJ.MicroRNA-328 is associated with (non-small) cell lung Veer LJ, Perou CM. Concordance among gene-expression-based
cancer (NSCLC) brain metastasis and mediates NSCLC migration. predictors for breast cancer. N Engl J Med 2006;355:560-9.
Int J Cancer 2011;129:2621-31. 89. Egeblad M, Werb Z. New functions for the matrix metalloproteinases
71. Tano K, Akimitsu N. Long noncoding RNAs in cancer progression. in cancer progression. Nature Rev Cancer 2002;2:161-74.
Front genet 2012;3:219. 90. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR,
72. Shen L, Chen L, Wang Y, Jiang X, Xia H, Zhuang Z. Long noncoding Massagué J. TGFbeta primes breast tumors for lung metastasis
RNA MALAT1 promotes brain metastasis by inducing epithelial- seeding through angiopoietin-like 4. Cell 2008;133:66-77.
mesenchymal transition in lung cancer. J Neurooncol 2015;121:101-8. 91. Adams JC. Roles of fascin in cell adhesion and motility. Curr Opin
73. Mittelbronn M, Warth A, Meyermann R, Goodman S, Weller M. Cell Biol 2004;16:590-6.
Expression of integrins alphavbeta3 and alphavbeta5 and their 92. Dall’Olio F, Chiricolo M. Sialyltransferases in cancer. Glycoconj J
ligands in primary and secondary central nervous system neoplasms. 2001;18:841-50.
Histol Histopathol 2012;33:405-12. 93. Palmieri D, Fitzgerald D, Shreeve SM, Hua E, Bronder JL, Weil RJ,
74. Vogetseder A, Thies S, Ingold B, Roth P, Weller M, Schraml Davis S, Stark AM, Merino MJ, Kurek R, Mehdorn HM, Davis G,
P, Goodman SL, Moch H. Alphav-Integrin isoform expression Steinberg SM, Meltzer PS, Aldape K, Steeg PS. Analyses of resected
in primary human tumors and brain metastases. Int J Cancer human brain metastases of breast cancer reveal the association
2013;133:2362-71. between up-regulation of hexokinase 2 and poor prognosis. Mol
75. Lorger M, Krueger JS, O’Neal M, Staflin K, Felding-Habermann Cancer Res 2009;7:1438-45.
B. Activation of tumor cell integrin αvβ3 controls angiogenesis 94. Smith TA. Mammalian hexokinases and their abnormal expression in
and metastatic growth in the brain. Proc Natl Acad Sci USA cancer. Br J Biomed Sci 2000;57:170-8.
2009;106:10666-71. 95. Brastianos PK, Carter SL, Santagata S, Cahill DP, Taylor-Weiner A,
76. Berghoff AS, Kovanda AK, Melchardt T, Bartsch R, Hainfellner JA, Jones RT, Van Allen EM, Lawrence MS, Horowitz PM, Cibulskis
Sipos B, Schittenhelm J, Zielinski CC, Widhalm G, Dieckmann K, K, Ligon KL, Tabernero J, Seoane J, Martinez-Saez E, Curry WT,

Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ March 11, 2016 ¦ 99